통증 관리 치료제 시장 : 치료제별, 적응증별, 유통 채널별 - 세계 전망(2025-2030년)

The Pain Management Therapeutics Market was valued at USD 82.66 billion in 2023, expected to reach USD 86.51 billion in 2024, and is projected to grow at a CAGR of 4.74%, to USD 114.35 billion by 2030.

The scope of the Pain Management Therapeutics market encompasses a variety of treatments designed to alleviate chronic and acute pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and antidepressants. This market is driven by the necessity to address the growing prevalence of chronic diseases, an aging population, and increasing surgical procedures which heighten the demand for effective pain management solutions. The primary applications involve treatments for conditions such as arthritis, cancer, neuropathic pain, and post-operative pain, catering to healthcare facilities, homecare settings, and rehabilitation centers. The market's end-use scope prominently includes hospitals, ambulatory surgical centers, and specialized pain management clinics, with robust utilization of these therapeutics by healthcare professionals and patients aiming for improved quality of life.

Market growth is significantly influenced by factors such as technological advancements, increasing patient awareness, and supportive government initiatives for pain management programs. Additionally, the development of non-opioid pain medication and biologics presents potential opportunities for stakeholders eager to reduce reliance on addictive opioids and address unmet medical needs. However, stringent regulatory requirements, side effects related to pain medications, and the emergence of counterfeit drugs pose notable constraints and challenges. The ever-looming opioid crisis also feeds into the market's complexities, resulting in heightened scrutiny and sporadic policy shifts that could hinder market stability and growth.

Innovative opportunities lie in the research and development of precision medicine approaches, personalized pain management solutions, and the integration of digital health technologies, such as patient monitoring and telehealth, to enhance treatment efficacy and patient adherence. The market is mature, yet evolving as it adapts to new health trends and technological advancements. The best future strategies involve focusing on developing cost-effective non-opioid pain therapeutics, leveraging artificial intelligence for predictive analytics in pain management, and expanding patient education initiatives for safer and more effective pain management practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pain Management Therapeutics Market

The Pain Management Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in incidences of chronic diseases
  • Growing geriatric population
  • Increase in incidence of accidental and sports injuries
• Market Restraints
  • Availability of substitutes such as pain relief devices
  • Absence of a perfect pain management solution
• Market Opportunities
  • Improving healthcare infrastructure in emerging countries
  • Ongoing research and development in the pain therapeutics
• Market Challenges
  • Risk of side effects of pain medications such as sedation and nausea

Porter's Five Forces: A Strategic Tool for Navigating the Pain Management Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pain Management Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pain Management Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pain Management Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pain Management Therapeutics Market

A detailed market share analysis in the Pain Management Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pain Management Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pain Management Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pain Management Therapeutics Market

A strategic analysis of the Pain Management Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pain Management Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca, Eli Lilly & Company, Endo Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson Services, Mallinckrodt Pharmaceuticals Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Pain Management Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapeutics, market is studied across Anesthetics, Anticonvulsants, Antidepressants, Antimigraine Agents, Non-Narcotic Analgesics, Non-Steroidal Anti-inflammatory Drugs, and Opioids.
• Based on Indication, market is studied across Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, Migraine, Neuropathic Pain, and Post-Operative Pain.
• Based on Distribution Channel, market is studied across Hospitals Pharmacy, Online Pharmacy, and Retail Pharmacy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in incidences of chronic diseases
    • 5.1.1.2. Growing geriatric population
    • 5.1.1.3. Increase in incidence of accidental and sports injuries
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of substitutes such as pain relief devices
    • 5.1.2.2. Absence of a perfect pain management solution
  • 5.1.3. Opportunities
    • 5.1.3.1. Improving healthcare infrastructure in emerging countries
    • 5.1.3.2. Ongoing research and development in the pain therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of side effects of pain medications such as sedation and nausea
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pain Management Therapeutics Market, by Therapeutics

• 6.1. Introduction
• 6.2. Anesthetics
• 6.3. Anticonvulsants
• 6.4. Antidepressants
• 6.5. Antimigraine Agents
• 6.6. Non-Narcotic Analgesics
• 6.7. Non-Steroidal Anti-inflammatory Drugs
• 6.8. Opioids

7. Pain Management Therapeutics Market, by Indication

• 7.1. Introduction
• 7.2. Arthritic Pain
• 7.3. Cancer Pain
• 7.4. Chronic Back Pain
• 7.5. Fibromyalgia
• 7.6. Migraine
• 7.7. Neuropathic Pain
• 7.8. Post-Operative Pain

8. Pain Management Therapeutics Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospitals Pharmacy
• 8.3. Online Pharmacy
• 8.4. Retail Pharmacy

9. Americas Pain Management Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pain Management Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pain Management Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca
• 3. Eli Lilly & Company
• 4. Endo Pharmaceuticals Inc.
• 5. F. Hoffmann La Roche Ltd.
• 6. GlaxoSmithKline Plc
• 7. Johnson & Johnson Services
• 8. Mallinckrodt Pharmaceuticals Company
• 9. Merck & Co. Inc.
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Purdue Pharma L.P.
• 13. Teva Pharmaceutical Industries Ltd.